The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
|Articles|June 3, 2011
New: Shimadzu News Pharma Special
Shimadzu has launched a Special Edition of the Shimadzu-News specifically for the needs of the pharmaceutical industry.
Advertisement
Shimadzu has launched a Special Edition of the Shimadzu-News specifically for the needs of the pharmaceutical industry. 40 pages introduce solutions and applications for a multitude of topics such as drug research, development and testing as well as method development, manufacturing and quality control.
The applications cover many disciplines of analytical instrumentation, e.g. chromatography, TOC and spectroscopy. In-detail, in-depth articles describe new as well as established methods. In a highly regulated environment, the pharmaceutical industry depends on increasingly sensitive measurements, and the same time efficiency, cost-effectiveness and ecology.
Some selected highlights: TOC analysis of ultra pure water, detection of heavy metals by EDX, impurity analysis by two dimensional LC and LCMS-IT-TOF, and extrusion testing of blister packaging. The new Crude2Pure system, jointly developed by Shimadzu Corporation and GlaxoSmithKline UK, demonstrates Shimadzu’s innovation and ability to provide tailor-made technologies.
Shimadzu Pharma News is available for download at
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Advertisement
Advertisement